Endothelial progenitor cells and translational research: Editors' view

British Journal of Clinical Pharmacology

Volumn 68, Issue 4, 2009, Pages 477-479

  Ritter, J M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACOLOGY; CLINICAL PRACTICE; EDITORIAL; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; STEM CELL;

ENDOTHELIAL CELLS; HUMANS; STEM CELLS; TRANSLATIONAL RESEARCH;

EID: 70449089072     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03538.x     Document Type: Editorial

References (18)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 : 373 376.
2. Asahara T, Murohara T, Sullivan A, Silver M, Van Der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 : 964 967.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularisation. Circ Res 1999 85 : 221 228.
4. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. Endothelial cells of haemopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000 87 : 728 730.
5. Aronson JK, Cohen A, Lewis LD. Clinical Pharmacology - providing tools and expertise for translational medicine. Br J Clin Pharmacol 2008 65 : 154 157.
6. Tilling L, Chowienczyk P, Clapp B. Progenitors in motion: mechanisms of mobilisation of endothelial progenitor cells. Br J Clin Pharmacol 2009 68 : 484 492.
7. Gordon SE, Cartwright N, Griffiths MJD. Investigation of endothelial function by pulse contour analysis: a protocol for drug administration and timing of pulse contour assessment. Br J Clin Pharmacol 2009 68 : 630 633.
8. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, Ritter JM, Anggard EE. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol 1999 34 : 2007 2014.
9. Gustafsson H, Åkesson J, Li Lau C, Williams D, Miller L, Yap S, Rolan P. A comparison of two formulations of intradermal capsaicin as models of neuropathic pain in healthy volunteers. Br J Clin Pharmacol 2009 68 : 511 517.
10. Zoethout RWM, Schoemaker RC, Zuurman L, van Pelt J, Dahan A, Cohen AF, van Gerven JMA. Central nervous system effects of alcohol at a pseudo-steady-state concentration using alcohol clamping in healthy volunteers. Br J Clin Pharmacol 2009 68 : 524 534.
11. Zoethout RWM, van Gerven JMA, Dumont GJH, Paltansing S, van Burgel ND, van der Linden M, Dahan A, Cohen AF, Schoemaker RC. A comparative study of two methods for attaining constant alcohol levels. Br J Clin Pharmacol 2008 66 : 674 681.
12. O'Connor S, Morzorati S, Christian J, Li TK. Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 1998 22 : 202 210.
13. Ternant D, Hénin E, Cartron G, Tod M, Paintaud G, Girard P. Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma. Br J Clin Pharmacol 2009 68 : 561 573.
14. Bohm F, Pernow J. Urotensin II evokes potent vasoconstriction in humans in vivo. Br J Pharmacol 2002 135 : 25 7.
15. Wilkinson IB, Affolter JT, de Haas SL, Pellegrini MP, Boyd J, Winter MJ, Balment RJ, Webb DJ. High plasma concentrations of human urotensin II do not alter local or systemic haemodynamics in man. Cardiovasc Res 2002 53 : 341 347.
16. Cheriyan J, Burton TJ, Bradley TJ, Wallace SML, Mäki- Petäjä KM, Mackenzie IS, McEniery CM, Brown J, Wilkinson IB. The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans. Br J Clin Pharmacol 2009 68 : 518 523.
17. Pastacchini R, Santicioli P, Giuliani S, Grieco P, Novellino E, Rovero P, Maggi CA. Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta. Br J Pharmacol 2003 140 : 1155 1158.
18. Sidharta PN, Rave K, Heinemann L, Chiossi E, Krahenbuhl S, Dingermanse J. Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type II diabetes mellitus. Br J Clin Pharmacol 2009 68 : 502 510.